Table 3.
Cytomorphologic feature | Atypical malignant n = 18 | Non-neoplastic n = 10 |
Increased cellularity | 11 (61.1%) | 1 (10%) |
Clustering | 11 (61.1%) | 3(30%) |
Papillae | 3(16.67%) | 0 |
Comet cells | 7 (38.9%) | 0 |
India-ink cells | 5 (27.78%) | 0 |
Necrosis | 9 (50%) | 4(40%) |
Apoptosis | 9 (50%) | 0 |
Shape and size changes | 15 (83.33%) | 7(70%) |
High nuclear/cytoplasmic ratio | 15 (83.33%) | 0 |
Cytoplasmic alterations | 8 (44.44%) | 0 |
Nuclear pleomorphism | 17(94.44%) | 6(60%) |
Irregular margin | 16 (88.9%) | 2(20%) |
Hyperchromasia | 17 (94.44%) | 0 |
Chromatin abnormalities | 18 (100%) | 0 |